<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Systemic treatment of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> currently means intravenous infusion of plasminogen activator in patients with the <z:hpo ids='HP_0001297'>stroke</z:hpo> syndrome after exclusion of brain <z:mp ids='MP_0001914'>hemorrhage</z:mp> irrespective of whether thrombotic arterial obstruction is present or not </plain></SENT>
<SENT sid="1" pm="."><plain>In contrast, local intra-arterial treatment requires digital subtraction angiography and means direct treatment of the arterial pathology with the aim of recanalization and brain tissue reperfusion </plain></SENT>
<SENT sid="2" pm="."><plain>Randomized controlled trials that test these two treatment approaches are missing </plain></SENT>
<SENT sid="3" pm="."><plain>This paper discusses whether the time-saving systemic treatment approach is more promising for <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> patients than is the time-consuming endovascular local approach </plain></SENT>
</text></document>